Close
Nordic 9Nordic 9

Break Off Capital (investor - Private Equity)

United Kingdom capital.breakoff.com
See something wrong or missing? Let us know
Offices:London
Average round investment:2.78M USD
Average number per year:1.0
Distribution: 2020 (1)
Portfolio companies: Spain Made of Genes
Mostly invests in: Spain Spain (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Break Off Capital

Name Criteria
France Advent France Biotechnology
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain CG Health Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Dreamers Startup Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain FCV Equity
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Ulma
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Alpine Capital AS
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Artal AS
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Axilium Capital
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Simon Capital
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Broadview Ventures
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top